Effects lipoprotein success rate thrombolytic therapy acute myocardial infarction Lipoprotein Lp plasminogen share high degree homology amino acid deoxyribonucleic acid analysis Lp inactive high levels Lp profibrinolytic activity cell surface risk arteriosclerosis thrombosis competitive inhibition plasminogen present study high levels Lp influence thrombolytic therapy patients acute myocardial infarction patients acute myocardial infarction combination low-dose thrombolytic therapy recombinant tissue-type plasminogen activator rt-PA human single-chain urokinase-type plasminogen activator scu-PA regimen plasminemia lytic state well-maintained levels fibrinogen Coronary patency minutes initiation treatment Thrombolysis successful unsuccessful patients Patients high Lp levels equal mg/dl thrombolytic therapy patency patients normal low levels Lp patency difference Lp levels patients successful unsuccessful thrombolysis results high levels Lp thrombolysis patients acute myocardial infarction low-dose pharmacologic concentrations rt-PA scu-PA combination 